Use of tympanostomy tubes in otitis media

W. L. Meyerhoff

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Tympanostomy tubes (TT) are frequently employed as treatment for otitis media (OM) although there is little clinical or experimental evidence of their efficacy. Potential detriments of TT include cost, risk of inhalation anesthesia, intraoperative complications, and tympanic membrane (TM) damage. Potential benefits include elimination of the conductive hearing loss (CHL), reduction in the occurrence of acute purulent OM, and avoidance of sequelae. The cost/benefit ratio of TT has never been accurately determined and morbid complications of inhalation anesthesia and the surgical procedure appear to be rare. There is evidence that TT significantly reduce the CHL of OM as well as reduce the incidence of recurrent acute purulent OM and help avoid sequelae. It is therefore determined that the risk of TT insertion for middle ear effusion (occasional TN changes) can be justified, in properly selected patients, by the benefits (immediate improvement in hearing and reduction in the incidence of recurrent acute purulent OM).

Original languageEnglish (US)
Pages (from-to)537-542
Number of pages6
JournalAnnals of Otology, Rhinology and Laryngology
Volume90
Issue number6 I
StatePublished - 1981

Fingerprint

Middle Ear Ventilation
Otitis Media
Suppurative Otitis Media
Inhalation Anesthesia
Conductive Hearing Loss
Otitis Media with Effusion
Tympanic Membrane
Incidence
Intraoperative Complications
Hearing
Cost-Benefit Analysis
Costs and Cost Analysis

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Use of tympanostomy tubes in otitis media. / Meyerhoff, W. L.

In: Annals of Otology, Rhinology and Laryngology, Vol. 90, No. 6 I, 1981, p. 537-542.

Research output: Contribution to journalArticle

Meyerhoff, W. L. / Use of tympanostomy tubes in otitis media. In: Annals of Otology, Rhinology and Laryngology. 1981 ; Vol. 90, No. 6 I. pp. 537-542.
@article{6cff45d49d15437cad8531de72d122c5,
title = "Use of tympanostomy tubes in otitis media",
abstract = "Tympanostomy tubes (TT) are frequently employed as treatment for otitis media (OM) although there is little clinical or experimental evidence of their efficacy. Potential detriments of TT include cost, risk of inhalation anesthesia, intraoperative complications, and tympanic membrane (TM) damage. Potential benefits include elimination of the conductive hearing loss (CHL), reduction in the occurrence of acute purulent OM, and avoidance of sequelae. The cost/benefit ratio of TT has never been accurately determined and morbid complications of inhalation anesthesia and the surgical procedure appear to be rare. There is evidence that TT significantly reduce the CHL of OM as well as reduce the incidence of recurrent acute purulent OM and help avoid sequelae. It is therefore determined that the risk of TT insertion for middle ear effusion (occasional TN changes) can be justified, in properly selected patients, by the benefits (immediate improvement in hearing and reduction in the incidence of recurrent acute purulent OM).",
author = "Meyerhoff, {W. L.}",
year = "1981",
language = "English (US)",
volume = "90",
pages = "537--542",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "6 I",

}

TY - JOUR

T1 - Use of tympanostomy tubes in otitis media

AU - Meyerhoff, W. L.

PY - 1981

Y1 - 1981

N2 - Tympanostomy tubes (TT) are frequently employed as treatment for otitis media (OM) although there is little clinical or experimental evidence of their efficacy. Potential detriments of TT include cost, risk of inhalation anesthesia, intraoperative complications, and tympanic membrane (TM) damage. Potential benefits include elimination of the conductive hearing loss (CHL), reduction in the occurrence of acute purulent OM, and avoidance of sequelae. The cost/benefit ratio of TT has never been accurately determined and morbid complications of inhalation anesthesia and the surgical procedure appear to be rare. There is evidence that TT significantly reduce the CHL of OM as well as reduce the incidence of recurrent acute purulent OM and help avoid sequelae. It is therefore determined that the risk of TT insertion for middle ear effusion (occasional TN changes) can be justified, in properly selected patients, by the benefits (immediate improvement in hearing and reduction in the incidence of recurrent acute purulent OM).

AB - Tympanostomy tubes (TT) are frequently employed as treatment for otitis media (OM) although there is little clinical or experimental evidence of their efficacy. Potential detriments of TT include cost, risk of inhalation anesthesia, intraoperative complications, and tympanic membrane (TM) damage. Potential benefits include elimination of the conductive hearing loss (CHL), reduction in the occurrence of acute purulent OM, and avoidance of sequelae. The cost/benefit ratio of TT has never been accurately determined and morbid complications of inhalation anesthesia and the surgical procedure appear to be rare. There is evidence that TT significantly reduce the CHL of OM as well as reduce the incidence of recurrent acute purulent OM and help avoid sequelae. It is therefore determined that the risk of TT insertion for middle ear effusion (occasional TN changes) can be justified, in properly selected patients, by the benefits (immediate improvement in hearing and reduction in the incidence of recurrent acute purulent OM).

UR - http://www.scopus.com/inward/record.url?scp=0019844472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019844472&partnerID=8YFLogxK

M3 - Article

C2 - 7316375

AN - SCOPUS:0019844472

VL - 90

SP - 537

EP - 542

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 6 I

ER -